Lgt Fund Management CO Ltd. Regeneron Pharmaceuticals, Inc. Transaction History
Lgt Fund Management CO Ltd.
- $952 Million
- Q3 2024
A detailed history of Lgt Fund Management CO Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Lgt Fund Management CO Ltd. holds 452 shares of REGN stock, worth $322,004. This represents 0.05% of its overall portfolio holdings.
Number of Shares
452
Previous 496
8.87%
Holding current value
$322,004
Previous $521,000
8.83%
% of portfolio
0.05%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,534Shares Held
83.6MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.64 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.02 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.34 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.49 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.06 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $76.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...